Ulvi Bayraktutan is an Associate Professor in the Division of Clinical Neuroscience at the University of Nottingham. His research aims to develop clinical biomarkers and novel therapeutics for (physio)pathological conditions associated with neurodegeneration and/or endothelial dysfunction, notably stroke, hypertension, diabetes and ageing. He performs preclinical, translational and clinical research to achieve these goals.
He acts as a reviewer for many high profile international journals and is an editorial board member of four different journals. He provides expert opinion or advice to a number of national and international research councils, charities, healthcare companies, societies and institutions.
He has been a Fellow of Higher Education Academy (FHEA) since 2007 and supervised many postgraduate studies for the degrees of MSc, MD and PhD.
Dr Bayraktutan is the Chief investigator of the Dunhill Medical Trust EPC study investigating the specific effect of ageing on the circulatory level and functional aspects of endothelial progenitor cells as well as the diagnostic and prognostic value of endothelial progenitor cells in elderly patients with lacunar or cortical stroke.
Find out more:
Neuroscience, neurodegeneration, cell biology, stem cells, endothelial progenitor cells, regenerative medicine, cell-based therapeutics, clinical biomarkers, blood-brain barrier pathophysiology, stroke, endothelial function, vascular dysfunction, cytoskeleton, neurovascular protection, ageing, apoptosis, novel therapeutics, hypothermia, oxidative stress, experimental models of human disease and molecular biology.
Aetiology of stroke, blood-brain barrier in stroke medicine and research, tutorials, BMedSci projects and postgraduate student teaching
· Molecular mechanisms of neurodegenerative diseases (Stroke and Multiple Sclerosis)
· Role of endothelial cell senescence in ageing and neurodegenerative diseases
· Regenerative medicine
· Identification and application of novel therapeutics for neurovascular conditions
· Clinical biomarkers
· Pioneering in vitro models of human cerebral disease
ALWJWAJ, M, ABDULKADIR, RR and BAYRAKTUTAN, U, 2021. The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke Neural Regeneration Research. 16(8), 1483-1489
BAYRAKTUTAN, U, 2021. Prognostic, Diagnostic and Therapeutic Potential of Endothelial Progenitor Cells for Patients with Ischaemic Stroke: hype or hope BIOCELL. (In Press.)